Delivery Order SPE2DR25D1017-SPE2DR26F9DGR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,977.73 to AmerisourceBergen Drug Corp for the supply of Keppra (levetiracetam) 1,000 mg tablets in quantities of 60 units. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, issued on January 6, 2026. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $44,146.22 to AmerisourceBergen Drug Corp for the supply of Keppra 500 mg tablets (120-count units). This competitively awarded, firm fixed-price contract has an ultimate completion date of November 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating the contract was competed among all eligible vendors. Keppra is a neurological...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $23,902.41 by the Defense Logistics Agency on January 5, 2026, for the supply of Keppra 500 mg tablets (120-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 6, 2026, and represents a child award under AmerisourceBergen's broader relationship with DLA. The performance location is the company's...
- The Defense Logistics Agency Troop Support Medical awarded a $1,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 milligram tablets of Keppra anti-seizure medication. Under the contract, Amerisourcebergen will deliver 60 tablets of Keppra to its place of performance in Conshohocken, Pennsylvania, with work occurring between August 17-18, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill this requirement for the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at $21,613.75 to AmerisourceBergen Drug Corp for the supply of Keppra 500 mg tablets (120-count units) under a firm fixed price contract. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and does not utilize a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this contract. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $43,554.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 milligram tablets of Keppra anti-seizure medication. Under this order, Amerisourcebergen will deliver 60 count bottles of Keppra to a location in Conshohocken, Pennsylvania by July 31, 2023. As a top provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen routinely supports the DLA's mission to provide critical medical materiel...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,076.37 on August 14, 2025, for the supply of Keppra 750 mg tablets (120-count units). The contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain. No set-aside designation was applied to this competitively awarded contract,...
- The Defense Logistics Agency awarded a delivery order valued at $31,584.28 to AmerisourceBergen Drug Corp for the supply of Keppra (levetiracetam) 1,000 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency on January 8, 2026, for the supply of Keppra 500 mg tablets (120-count units) valued at $5,467.82. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 9, 2026. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Keppra is an anti-seizure medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Keppra 100 mg/ml oral solution in a 473 ml quantity, valued at $5,366.29. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. Keppra is a neurological...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DGRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,978.89 to AmerisourceBergen Drug Corp for the supply of Keppra 750 mg tablets (120-count units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. Keppra (levetiracetam) is an anticonvulsant medication commonly used to treat seizure disorders in military and veteran populations. As a critical pharmaceutical distributor to federal medical systems, AmerisourceBergen maintains extensive capabilities to fulfill recurring medication needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's established presence as a prime pharmaceutical vendor to the Defense Logistics Agency demonstrates its proven ability to meet federal procurement requirements for essential medications across multiple therapeutic domains, including neurological treatments such as this seizure management medication.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 1/14/26 |